HIGHLIGHTS
- who: CD and colleagues from the DivisionCancer Center, La Jolla, California, USA Novartis, San Diego, California, USA. IconOVir Bio, San Diego, California, USA. have published the research: Authorship note: SEB and MSN are co-first authors. Conflict of interest: MSN, AMM, and SPS are listed as inventors on patent application WO2022/098750 A1 related to tumor-specific T cell receptors. SPS serves on the scientific advisory boards of 3T Biosciences and Telesis Bio, in the Journal: (JOURNAL) of September/20,/2022
- what: The authors investigated the capacity of CD4+ T_cells specific for the oncoproteins HPV . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.